GregoryM.PastoresMD
Medical Genetics • New York, NYClinical Genetics, Clinical Molecular Genetics
Physician
Dr. Pastores is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Eccles Street
Dublin 7
New York, NY 10028
Summary
- Dr. Gregory Pastores is an Adult Metabolic Disease Specialist in Dublin, Ireland He received his medical degree from University of Santo Tomas (1983). He also speaks multiple languages, including Filipino and Spanish. He specializes in clinical, biochemical and molecular genetics.
Clinical Expertise
- Fabry disease, Lysosomal storage diseases, Enzyme replacement therapy, Splenomegaly, Severity of illness index, Pain measurement
Education & Training
Icahn School of Medicine at Mount Sinai1991 - 1992
Mayo Clinic Foundation1989 - 1991- Icahn School of Medicine at Mount Sinai (NYC Health and Hospitals: Elmhurst)Residency, Pediatrics, 1986 - 1989
University of Santo TomasClass of 1983
Certifications & Licensure
NY State Medical License 1989 - 2015
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Replagal Enzyme Replacement Therapy for Children With Fabry Disease Start of enrollment: 2004 Jun 10
- Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase Start of enrollment: 2007 Jul 25
- Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry Disease Start of enrollment: 2008 Dec 29
- Join now to see all
Publications & Presentations
PubMed
- 360 citationsFemales with Fabry disease frequently have major organ involvement : Lessons from the Fabry RegistryWilliam R. Wilcox, João Paulo Oliveira, Robert J. Hopkin, Alberto Ortiz, Maryam Banikazemi
Molecular Genetics and Metabolism. 2008-02-01 - 62 citationsOutcomes after 18 months of eliglustat therapy in treatment-naïve adults with Gaucher disease type 1: The phase 3 ENGAGE trial.Pramod K. Mistry, Elena Lukina, Hadhami Ben Turkia, Suma P. Shankar, Hagit N. Baris
American Journal of Hematology. 2017-11-01 - 102 citationsEffect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1: The ENGAGE Randomized Clinical TrialPramod K. Mistry, Elena Lukina, Hadhami Ben Turkia, Dominick Amato, Hagit N. Baris
JAMA. 2015-02-17
Other Languages
- Filipino, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
